Canadian study shows universal infant RSV immunisation drastically reduces hospitalisations and ICU admissions

A Canadian research initiative demonstrates that a free infant immunisation programme using nirsevimab has significantly lowered severe respiratory syncytial virus cases, hospital stays, and ICU use among babies in their first RSV season. A new Canadian study suggests a free…













